Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium Tetravaccine tablets (Siliankang) for constipation during pregnancy
ChiCTR2100047671Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Jun 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Bifidobacterium tetravaccine in constipation, sponsored by West China Second University Hospital. Primary endpoint: Frequency of spontaneous defecation. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
Bifidobacterium tetravaccine
03
Conditions
constipation
Beyond the preview
Go deeper on ChiCTR2100047671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047671.